DARE
Dare Bioscience, Inc. Common Stock
stockNASDAQ
daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.75 | 2026-09-28 | +12.32% | -8.417 |
| 1M | 0.72 | 2026-09-04 | +16.84% | 1.777 |
| 3M | 2.08 | 2026-07-06 | -59.50% | 1.698 |
| 6M | 1.81 | 2026-04-06 | -53.46% | 1.927 |
| 1Y | 2.18 | 2025-10-03 | -61.36% | 1.072 |
| 2Y | 3.23 | 2024-10-04 | -73.92% | — |
| 5Y | 19.20 | 2021-10-04 | -95.61% | 0.827 |
Dare Bioscience, Inc. Common Stock (NASDAQ:DARE) stock price today is $0.84, and today's volume is 148,399. DARE is down 1.011% today. The 30 day average volume is 337,268. DARE market cap is $16.57M with 19.67M shares outstanding.